Abbott Stock Plummets 1.79 as $0.53 Billion Volume Slumps 29.84 to 200th in Liquidity Ranking Amid Sector Correction

, 2025, , . The stock’s performance followed a mixed session where volume-driven momentum failed to offset broader market pressures.

Analysts noted the drop coincided with a broader sector-wide correction in healthcare equities, though specific catalysts tied to Abbott remained limited. The company’s recent earnings report had already been priced into the market, leaving investors without fresh guidance or product updates to drive sentiment.

To back-test this idea rigorously requires clarifying key parameters: defining the market universe (e.g., U.S. listed stocks), selecting ranking criteria (volume vs. dollar volume), establishing weighting rules, and setting execution assumptions. Transaction costs and benchmarks must also be specified to generate a data-retrieval pipeline capable of measuring cumulative returns, , and other performance metrics against a reference index.